Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma

NCT00435916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin

Interventions

DRUG: SGN-40

Sponsor

Seagen Inc.

Collaborators

[object Object]